KETANKUMAR GHAGHADA to Contrast Media
This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Contrast Media.
Connection Strength
8.147
-
Nanoparticle contrast-enhanced computed tomography of sporadic aortic aneurysm and dissection: Effect of nanoparticle size and contrast agent dose. Theranostics. 2025; 15(8):3462-3473.
Score: 0.735
-
Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future Opportunities. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb; 17(1):e70004.
Score: 0.728
-
A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden. Contrast Media Mol Imaging. 2021; 2021:6641384.
Score: 0.569
-
Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1534-1548.
Score: 0.555
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.542
-
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
Score: 0.512
-
Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors. Phys Med Biol. 2019 03 12; 64(6):065007.
Score: 0.486
-
Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
Score: 0.431
-
Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer. PLoS One. 2016; 11(3):e0152718.
Score: 0.397
-
Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc. 2012; 2012:27-35.
Score: 0.313
-
Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One. 2012; 7(4):e34496.
Score: 0.301
-
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011 Jan; 18(1):20-30.
Score: 0.276
-
Liposomal contrast agents in brain tumor imaging. Neuroimaging Clin N Am. 2010 Aug; 20(3):367-78.
Score: 0.268
-
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
Score: 0.254
-
High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol. 2007 Jan; 28(1):48-53.
Score: 0.209
-
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Feb; 160:100-106.
Score: 0.182
-
Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
Score: 0.172
-
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
Score: 0.155
-
Photon Counting CT and Radiomic Analysis Enables Differentiation of Tumors Based on Lymphocyte Burden. Tomography. 2022 03 10; 8(2):740-753.
Score: 0.150
-
A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
Score: 0.119
-
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
Score: 0.104
-
A liposomal Gd contrast agent does not cross the mouse placental barrier. Sci Rep. 2016 06 14; 6:27863.
Score: 0.101
-
Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent. Sci Rep. 2015 May 18; 5:10178.
Score: 0.093
-
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94.
Score: 0.080
-
High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):18-22.
Score: 0.074
-
High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent. Magn Reson Med. 2009 Dec; 62(6):1447-56.
Score: 0.064
-
Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol. 2007 Mar; 14(3):355-62.
Score: 0.053
-
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med. 2006 May; 55(5):1023-9.
Score: 0.050
-
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol. 2006 Feb; 186(2):300-7.
Score: 0.049
-
Micro-CT imaging of multiple K-edge elements using GaAs and CdTe photon counting detectors. Phys Med Biol. 2023 04 12; 68(8).
Score: 0.040
-
Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
Score: 0.030
-
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev. 2014 Sep 30; 76:79-97.
Score: 0.022
-
Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano. 2013 Apr 23; 7(4):3118-29.
Score: 0.020
-
Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine. 2009; 4:277-82.
Score: 0.015